AR
Acrux Limited
ARUXF · OTC
$0.02 +412.12% (+$0.01)
Market Cap $9.52M
P/E Ratio -
Div. Yield -
ROE 34.00%
Piotroski F-Score Weak
2/9Valuation
76 /100
Cheap P/S 2.05x
P/B 6.50x
P/FCF 9.36x
Growth
34 /100
Stable Rev. growth 18.06%
FCF growth 20.33%
Book val. growth 44.77%
Profitability
50 /100
Moderate Gross margin 90.57%
Net margin 13.01%
FCF margin 21.94%
Quality
9 /100
Poor ROIC 10.70%
ROE 34.00%
Asset turnover 0.68x
Debt
28 /100
High Debt/Equity 1.72x
Current ratio 1.37x
Int. coverage -7.59x
Stability
24 /100
Unstable Beta 0.97x
Rev. volatility 201.66%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ARUXF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John Warmbrunn
Employees
43
Headquarters
West Melbourne
Prihajajoči dogodki
02 MAR.
Earnings
Upcoming earnings report